Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07128901 · ClinicalTrials.gov registry record · NA
Lower-Limb Exoskeleton Technology for Non-Ambulatory Individuals With Spinal Cord Injury
A NA study of Spinal Cord Injuries, sponsored by Georgia Institute of Technology.
- Recruiting
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT07128901: Recruiting NA study of Spinal Cord Injuries, sponsored by Georgia Institute of Technology.
NCT07128901 is a NA study of Spinal Cord Injuries that is actively recruiting participants, run by Georgia Institute of Technology. The registered enrollment target is 6 participants, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07128901, a NA study of Spinal Cord Injuries, is actively recruiting participants, sponsored by Georgia Institute of Technology.
- RECRUITING
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare two types of wearable lower-extremity exoskeletons -a self-balancing device lower-extremity exoskeleton and a user-balancing device lower-extremity exoskeleton-to better understand their effects on the physiological responses to walking and the user experience in people with spinal cord injury.
Primary Outcome
This will be measured as the participant walks a distance of 10 meters at their self-selected (or comfortable) walking speed. Three 10-meter walk trials will be completed by each participant at each time point. The average of three 10MWT walking speeds will be analyzed and reported. This measure will be recorded in seconds and converted to meters/s with higher values indicating faster speed and lower values indicating slower speeds. Self-selected walking speed is highly correlated with functiona
Conditions Studied
Interventions
- DEVICE Ekso Indego Therapy
- DEVICE Wandercraft Atalante X
Study Locations (1)
Georgia
- The Shepherd Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2025-12-10 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What NCT07128901 shows while recruiting
NCT07128901 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 2 interventions - of which Ekso Indego Therapy is the first listed.
NCT07128901 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT07128901 about?
NCT07128901 is a clinical study titled "Lower-Limb Exoskeleton Technology for Non-Ambulatory Individuals With Spinal Cord Injury". The purpose of this study is to compare two types of wearable lower-extremity exoskeletons -a self-balancing device lower-extremity exoskeleton and a user-balancing device lower-extremity exoskeleton-to better understand their effects on the physiological responses to walking and the user experience...
What is the current status of trial NCT07128901?
This trial is currently recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2025-12-10. Estimated completion is 2026-12-01.
What conditions does trial NCT07128901 study?
This clinical trial studies the following conditions: Spinal Cord Injuries.
What interventions are being tested in trial NCT07128901?
The interventions under investigation include: Ekso Indego Therapy (DEVICE), Wandercraft Atalante X (DEVICE).
Who is sponsoring clinical trial NCT07128901?
This trial is sponsored by Georgia Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07128901 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07128901's enrollment target sits among peer trials
6 183rd of 202 higher than 14 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy